John Edward Hunt Iii, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1377 Motor Pkwy, Islandia, NY 11749 Phone: 631-635-5900 Fax: 631-635-5940 |
News Archive
In an effort to limit possible prescription narcotic misuse and dependence among its members, Blue Cross Blue Shield of Massachusetts (BCBSMA) announced today that it is instituting enhanced safety measures on how it will cover the use of powerful pain killers.
Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that the European Patent Office has issued a notice of Intention to Grant a European Patent that provides protection for the Company's PENNSAID 2% product.
U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced the award of $16.8 million to support 27 Public Health Training Centers (PHTC) at schools of public health and other public or non-profit institutions across the country. The PHTC Program helps improve the public health system by enhancing skills of the current and future public health workforce.
The Stowers Institute's Pourquié Lab has demonstrated the role of fibroblast growth factor (FGF) in the embryonic process of somitogenesis, an event required for vertebrae formation, in a paper posted to the Web site of the journal Development.
Once-daily treatment of patients with chronic obstructive pulmonary disease (COPD) with an inhaler combining fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) reduced all-cause mortality by 42 percent, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
› Verified 7 days ago